Drug details

Vitrasert (ganciclovir)

type of

Vitrasert (ganciclovir) is an antiviral implant used to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). The brand name Vitrasert is discontinued, but generic versions may be available.

This drug may have the following side effects:

• vision changes
• eye redness
• sensitivity to light
• cataracts
• blurred vision (may last up to 4 weeks after Vitrasert is implanted)
• eye irritation
• increased tearing
• eye pain or swelling
• burning or itching eyes
• vitreous hemorrhage
• retinal detachments
• eye abnormalities and other eye problems or visual disturbances

The following supplements are related to Vitrasert, and may be used together with the drug:

• Coenzyme Q-10 (s.)
• Glutamine (s.)
• Hydroxymethylbutyrate (Hmb) (s.)
• L-Arginine (s.)
• Lentinan (s.)
• Marijuana (s.)
• Saccharomyces Boulardii (s.)
• Same (s.)
• Sangre De Grado (s.)
• Vitamin A (s.)
• Whey Protein (s.)